openPR Logo
Press release

Lamellar Icthyosis Pipeline Therapeutics Assessment Report 2024 (Updated)

12-04-2024 12:21 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Lamellar Icthyosis Pipeline

Lamellar Icthyosis Pipeline

DelveInsight's, "Lamellar Icthyosis Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Lamellar Icthyosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Lamellar Icthyosis Research. Learn more about our innovative pipeline today! @ Lamellar Icthyosis Pipeline Outlook- https://www.delveinsight.com/sample-request/lamellar-icthyosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Lamellar Icthyosis Pipeline Report
• In March 2024:- Northwestern University- Ichthyosis is a group of genetic skin disorders that present with dry, thickened, scaly, or flaky skin. As of today, there is no cure or treatment. Doctors can only treat the dry skin with different types of emollients to soften the scale. A deeper understanding of this disease is required to develop better treatments. There are different types of cells and cell-produced signals (biomarkers) that are being studied in order to help find these new treatments. Looking at biomarkers has been successful in helping us to understand other skin disorders better. The purpose of this study is to determine which blood and skin biomarkers characterize ichthyosis.
• DelveInsight's Lamellar Icthyosis pipeline report depicts a robust space with 4+ active players working to develop 5+ pipeline therapies for Lamellar Icthyosis treatment.
• The leading Lamellar Icthyosis Companies such as Timber Pharmaceuticals, Krystal Biotech, Janssen, and others.
• Promising Lamellar Icthyosis Therapies such as KB105, TMB-001, and others

Stay informed about the cutting-edge advancements in Lamellar Icthyosis treatments. Download for updates and be a part of the revolution in care @ Lamellar Icthyosis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/lamellar-icthyosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lamellar Icthyosis Emerging Drugs Profile

• TMB-001: Timber Pharmaceuticals
TMB-001 (0.05% and 0.1% isotretinoin) is under clinical development as a topical therapy for the treatment of congenital ichthyosis, including recessive X-linked ichthyosis and autosomal recessive congenital ichthyosis-lamellar ichthyosis subtypes. The US FDA and the EMA granted orphan drug designation to TMB 001 for the treatment of congenital ichthyosis. In 2018, the FDA awarded $1.5 million to support Phase IIa and Phase IIb clinical trials evaluating TMB-001 through its Orphan Products Grant program. During the fourth quarter of 2021, Timber announced positive top line results for its Phase IIb CONTROL Study. Clinically meaningful efficacy with a favorable safety profile demonstrated the potential of TMB-001 to be an important option for the treatment of CI where the options for standard of care is limited. The Company is currently being evaluating the drug in Phase III stage of its development.

• KB105: Krystal Biotech
KB105 is a gene therapy-based therapeutic, currently in Phase II clinical study to treat patients with TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI). KB105 is a replication-defective, non-integrating viral vector that has been engineered employing Krystal's technology platform to deliver a functional human TGM1 gene directly to the patients' dividing and non-dividing skin cells. HSV-1 is Krystal's replication-deficient, non-integrating viral vector that can penetrate skin cells more efficiently than other viral vectors.

Learn more about Lamellar Icthyosis Drugs opportunities in our groundbreaking Lamellar Icthyosis Research and development projects @ Lamellar Icthyosis Unmet Needs- https://www.delveinsight.com/sample-request/lamellar-icthyosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lamellar Icthyosis Companies
Timber Pharmaceuticals, Krystal Biotech, Janssen, and others.

Lamellar Icthyosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical

Lamellar Icthyosis Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Discover the latest advancements in Lamellar Icthyosis treatment by visiting our website. Stay informed about how we're transforming the future of disease @ Lamellar Icthyosis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/lamellar-icthyosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Lamellar Icthyosis Pipeline Report
• Coverage- Global
• Lamellar Icthyosis Companies- Timber Pharmaceuticals, Krystal Biotech, Janssen, and others.
• Lamellar Icthyosis Therapies- KB105, TMB-001, and others
• Lamellar Icthyosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Lamellar Icthyosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Lamellar Icthyosis Pipeline on our website @ Lamellar Icthyosis Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/lamellar-icthyosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Lamellar Icthyosis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Lamellar Icthyosis- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. TMB-001: Timber Pharmaceuticals
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. KB105: Krystal Biotech
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Ustekinumab: Janssen
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Lamellar Icthyosis Key Companies
21. Lamellar Icthyosis Key Products
22. Lamellar Icthyosis- Unmet Needs
23. Lamellar Icthyosis- Market Drivers and Barriers
24. Lamellar Icthyosis- Future Perspectives and Conclusion
25. Lamellar Icthyosis Analyst Views
26. Lamellar Icthyosis Key Companies
27. Appendix

List of Highly Demanded Research Reports in 2024

cxcr inhibitors market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
fertility monitoring devices market: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market
ornithine transcarbamylase deficiency market: https://www.delveinsight.com/report-store/ornithine-transcarbamylase-deficiency-otc-deficiency-market
orthopedic power devices market: https://www.delveinsight.com/report-store/orthopedic-power-devices-market
otitis media market: https://www.delveinsight.com/report-store/otitis-media-market
persistent depressive disorder market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
smoking cessation market: https://www.delveinsight.com/report-store/smoking-cessation-market
surgical sealant market: https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
urothelial carcinoma market: https://www.delveinsight.com/report-store/urothelial-carcinoma-market
vascular grafts market: https://www.delveinsight.com/report-store/vascular-grafts-market
vital sign monitors devices market: https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
aplastic anemia market: https://www.delveinsight.com/report-store/aplastic-anemia-market
cart pipeline: https://www.delveinsight.com/report-store/car-t-pipeline-insight
celiac disease market: https://www.delveinsight.com/report-store/celiac-disease-cd-market
coronary stents market: https://www.delveinsight.com/report-store/coronary-stents-market-market
diabetic gastroparesis market: https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
elastomeric pump market: https://www.delveinsight.com/report-store/elastomeric-pump-market
friedreich's ataxia market: https://www.delveinsight.com/report-store/friedreichs-ataxia-market
hay fever conjunctivitis market: https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
hip replacement devices market: https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
joint reconstruction devices market: https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
periodontal disease market: https://www.delveinsight.com/report-store/periodontal-disease-market
psoriasis vulgaris market: https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
ranibizumab biosimilars market: https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
short bowel syndrome drug market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
short bowel syndrome market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
thrombectomy devices market: https://www.delveinsight.com/report-store/thrombectomy-devices-market
type 1 diabetes market: https://www.delveinsight.com/report-store/type-1-diabetes-market
adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
attention deficit hyperactivity disorder market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
avascular necrosis market: https://www.delveinsight.com/report-store/avascular-necrosis-market
biopsy devices market: https://www.delveinsight.com/report-store/biopsy-devices-market
embolotherapy market: https://www.delveinsight.com/report-store/embolotherapy-market
hydrocephalus treatment market: https://www.delveinsight.com/report-store/hydrocephalus-treatment-market
liquid biospy for cancer diagnostics market: https://www.delveinsight.com/report-store/liquid-biopsy-in-cancer-diagnostics-market
skin grafting devices market: https://www.delveinsight.com/report-store/skin-grafting-devices-market
testicular neoplasm market: https://www.delveinsight.com/report-store/testicular-neoplasm-market
uk healthcare report: https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
vascular access devices market: https://www.delveinsight.com/report-store/vascular-access-device-market
brucellosis market: https://www.delveinsight.com/report-store/brucellosis-market
catheter stabilization devices market: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
dyspepsia market: https://www.delveinsight.com/report-store/functional-dyspepsia-market-share
heart pump devices market: https://www.delveinsight.com/report-store/heart-pump-device-market
phototherapies for psoriasis market: https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
radial artery compression device market: https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
sarcopenia market: https://www.delveinsight.com/report-store/sarcopenia-market
shingles market: https://www.delveinsight.com/report-store/shingles-market
surgical site infections market: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
venous ulcer market: https://www.delveinsight.com/report-store/venous-leg-ulcer-market
viscosupplementation devices market: https://www.delveinsight.com/report-store/viscosupplementation-devices-market
artificial disc market: https://www.delveinsight.com/report-store/artificial-disc-market
healthcare consulting solutions: https://www.delveinsight.com/consulting
meningococcal meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
moderate to severe plaque psoriasis market: https://www.delveinsight.com/blog/us-psoriasis-treatment
pertussis market: https://www.delveinsight.com/report-store/pertussis-market
spinal trauma devices market: https://www.delveinsight.com/report-store/spinal-trauma-devices-market-market
surgical energy instruments market: https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
temporomandibular disorders market: https://www.delveinsight.com/report-store/temporomandibular-disorders-market
transcatheter heart valve replacement devices market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
urinary catheters market: https://www.delveinsight.com/report-store/urinary-catheters-market
attention deficit hyperactivity disorder adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
coronary angioplasty market: https://www.delveinsight.com/report-store/coronary-stents-market-market
nonalcoholic steatohepatitis market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
orthopedic splints device market: https://www.delveinsight.com/report-store/orthopedic-splints-market
perennial allergic rhinitis market: https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
pipeline assessment services: https://www.delveinsight.com/consulting/pipeline-assessment-services
schistosomiasis market: https://www.delveinsight.com/report-store/schistosomiasis-market
venous thromboembolism market: https://www.delveinsight.com/report-store/venous-thromboembolism-market
bacterial meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
nk cell therapy market: https://www.delveinsight.com/report-store/nk-cell-therapy-market
overactive bladder syndrome market: https://www.delveinsight.com/report-store/overactive-bladder-market
peripheral nerve injuries market: https://www.delveinsight.com/report-store/peripheral-nerve-injuries-market
tendonitis market: https://www.delveinsight.com/report-store/tendonitis-market
endoscopic ultrasound market: https://www.delveinsight.com/report-store/endoscopic-ultrasound-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lamellar Icthyosis Pipeline Therapeutics Assessment Report 2024 (Updated) here

News-ID: 3771333 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Lamellar

Lamellar Ichthyosis Market Dynamics Indicate Upward Trajectory Through 2032, Rep …
DelveInsight's "Lamellar Ichthyosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Lamellar Ichthyosis, historical and forecasted epidemiology as well as the Lamellar Ichthyosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Lamellar Ichthyosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lamellar Ichthyosis Market Forecast https://www.delveinsight.com/sample-request/lamellar-ichthyosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Lamellar Ichthyosis Market Industry Market Analysis, Share, and Growth Insights …
"CoherentMI has released a statistical report titled "Lamellar Ichthyosis Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, global presence, market share, pricing, locations of production facilities, and the introduction
Lamellar Ichthyosis Market Growth Anticipated by 2032 | Major Players: Krystal B …
The lamellar ichthyosis market landscape is expected to evolve with increased interest from pharmaceutical companies in developing new treatments, advancements in diagnostic techniques, and the anticipated introduction of emerging therapies during the forecast period. The market for Lamellar Ichthyosis is poised for significant growth between 2019 and 2032, according to the latest report, "Lamellar Ichthyosis Market Insights, Epidemiology, and Market Forecast 2032 [https://www.delveinsight.com/report-store/lamellar-ichthyosis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" from DelveInsight. The landscape of this market is
Lamellar Ichthyosis Market Insights | Anticipating Growth and Advancements by 20 …
Latest "Lamellar Ichthyosis Market" Size, Share & Trends Analysis Research Report 2024 - By Applications (Auto Sales, Employment Opportunities, Rental Properties, Pets, Other), By Types (Featured ads, Normal ad), By Segmentation analysis, Regions and Forecast to 2031. The Global Lamellar Ichthyosis market Report provides In-depth analysis on the market status of the Lamellar Ichthyosis Top manufacturers with best facts and figures, meaning, Definition, SWOT analysis, PESTAL analysis, expert opinions and
Lamellar Ichthyosis Treatment Market
Lamellar Ichthyosis Treatment Market Overview The global Lamellar Ichthyosis Treatment Market is anticipated to achieve a high CAGR during the forecast period spanning from 2023 to 2030. Understanding Lamellar Ichthyosis Lamellar Ichthyosis, also known as collodion baby or congenital lamellar ichthyosis, is a rare genetic skin disorder present at birth. It falls under the category of autosomal recessive congenital ichthyoses (ARCI) and is characterized by cutaneous redness and extensive scaling. Caused by harmful
PET Lamellar Film Market Research Report: Types,Volume,Revenue and Industry Anal …
Global Info Research announces the release of the report "Global PET Lamellar Film Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.